Results 201 to 210 of about 29,560 (219)
Some of the next articles are maybe not open access.

Theranostics in Neuroblastoma

PET Clinics, 2021
Theranostics combines diagnosis and targeted therapy, achieved by the use of the same or similar molecules labeled with different radiopharmaceuticals or identical with different dosages. One of the best examples is the use of metaiodobenzylguanidine (MIBG). In the management of neuroblastoma-the most common extracranial solid tumor in children.
Margarida Simao Rafael   +5 more
openaire   +3 more sources

Theranostic Nanomedicine

Accounts of Chemical Research, 2011
Nanomedicine formulations aim to improve the biodistribution and the target site accumulation of systemically administered (chemo)therapeutic agents. Many different types of nanomedicines have been evaluated over the years, including for instance liposomes, polymers, micelles and antibodies, and a significant amount of evidence has been obtained ...
Lammers T.   +4 more
openaire   +6 more sources

Theranostic of biopharmaceuticals

Pharmacology & Therapeutics, 2017
Monoclonal antibodies (mAbs) and fusion proteins with an Fc portion of immunoglobulin G (IgG) are emblematic of the remarkable expansion of biopharmaceuticals. Despite their biological origin, these products display an interindividual variability in their efficacy and/or side effects, which must be taken into consideration.
Benjamin Chaigne   +2 more
openaire   +3 more sources

General Concepts in Theranostics

PET Clinics, 2021
Theranostics describes the pairing of diagnostic biomarkers and therapeutic agents with common specific targets. Nuclear medicine is the greatest theranostics protagonist, relying on radioactive tracers for imaging biologic phenomena and delivering ionizing radiation to the tissues that take up those tracers.
Carlos Alberto Buchpiguel   +6 more
openaire   +3 more sources

Polymersomes for theranostics

Journal of Drug Delivery Science and Technology, 2013
In spite of the clear potential of personalized medicine, its pace of implementation has not yet fulfilled initial hopes. Polymeric vesicles, also named polymersomes, are presented as versatile systems able to address issues of efficacy, specificity and controlled release of drugs in a wide range of pathological scenarios that might show the way to ...
Hugo Oliveira   +2 more
openaire   +2 more sources

Theranostics of Thyroid Cancer

Seminars in Nuclear Medicine
Molecular imaging is pivotal in evaluating and managing patients with different thyroid cancer histotypes. The existing, pathology-based, risk stratification systems can be usefully refined, by incorporating tumor-specific molecular and molecular imaging biomarkers with theranostic value, allowing patient-specific treatment decisions. Molecular imaging
Luca Giovanella   +5 more
openaire   +3 more sources

Theranostics

2016
This chapter discusses the applications of various nanomaterials employed in two modalities, that is, therapy and imaging. The concept of theranostics is the combination of both therapeutics and diagnostics in one package for image-guided therapy and also for defining the treatment outcome at an early stage.
Inkyu Park   +3 more
openaire   +2 more sources

Nanoparticles in endothelial theranostics

Pharmacological Reports, 2015
The paper presents the recent advances in the development and studies of multifunctional nanoparticles which can be used to prevent/cure the cardiovascular diseases by detecting, treating and monitoring the early stages of atherosclerotic and thrombotic changes in endothelium.
Maria Nowakowska   +2 more
openaire   +3 more sources

Theranostics for Cancer Therapy

Current Drug Delivery, 2013
With over 10 million new cases per year worldwide, Cancer remains one of the most urgent health concerns and a difficult disease to treat. For an effective treatment, improved diagnostic and therapeutic techniques with minimal side-effects are required.
Sneha V. Jog   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy